Current Strategies, Diagnostic Approaches, and Advanced Therapeutics for the Treatment of Patients with Interstitial Lung Disease
CME/CE Symposium at the Congress of Clinical Rheumatology West Meeting
Date/Time
Sunday, September 19th, 2021
3:55 pm – 4:55 pm Pacific Time
Location
Hotel del Coronado
Ballroom
1500 Orange Avenue
Coronado, CA 92118
Target Audience
Rheumatologists, primary care physicians, physician assistants, nurse practitioners, nurses, hospital and community pharmacists, and other healthcare professionals involved in the treatment and management of patients with rheumatological disorders
Program Overview
This interactive CME/CE program will highlight recent advances in the treatment and management of patients with interstitial lung disease (ILD). The expert faculty, Dr. Elizabeth Volkmann, will first review best practices for screening and diagnosing patients. Following, recent clinical trial data of both emerging and approved agents will be analyzed, including that of nRTK and RTK inhibitors, and clinical relevance debated. To conclude, the faculty will relay strategies for engaging the interprofessional team to improve outcomes and quality of life for patients with interstitial lung disease.
Agenda
I. Advanced Therapeutics for Interstitial Lung Disease Treatment and Symptom Management
II. Clinical Trial Review: Emerging Treatment Options for ILD, Including nRTK and RTK Inhibitors
III. Engaging the Interprofessional Team to Build Positive Outcomes for Patients with ILD
IV. Question and Answers Segment
Educational Objectives
- Understand diagnostic methods and clinical presentations of ILD, as well as methods used to monitor lung function
- Review recent clinical trial data on therapeutic agents used to slow the rate of lung function decline, including nRTK and RTK inhibitors
- Engage in shared decision-making and communication with the interprofessional team while developing treatment plans for patients with ILD
Faculty
Elizabeth R. Volkmann, MD, MS
Director, UCLA Scleroderma Program
Founder and Co-Director
UCLA Connective Tissue Disease-Related Interstitial Lung Disease (CTD-ILD) Program
Los Angeles, California
Accreditation Statement
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AcademicCME designates this live material for a maximum of 1.0 AMA PRA Category 1 Credit ™.
AcademicCME designates this live material for a maximum of 1.0 CNE Contact Hour (Provider #P0491).
Participants should claim only the credit commensurate with the extent of their participation in the activity.
CE Inquiries/Special Needs
For all CME/CE inquiries or special needs, please contact [email protected] or 610-687-3300.
Financial Support
This activity has been supported by an independent educational grant from Boehringer Ingelheim
Provided by AcademicCME
*Further details regarding how to tune in to this live symposium will be emailed to the address used to register prior to the event.
